These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 638311)

  • 1. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
    Green AR
    Br J Pharmacol; 1978 Mar; 62(3):325-31. PubMed ID: 638311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.
    Green AR; Heal DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1977 Apr; 52(2):195-200. PubMed ID: 196304
    [No Abstract]   [Full Text] [Related]  

  • 7. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy.
    Costain DW; Green AR; Grahame-Smith DG
    Psychopharmacology (Berl); 1979 Mar; 61(2):167-70. PubMed ID: 108733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.
    Green AR; Heal DJ; Johnson P; Laurence BE; Nimgaonkar VL
    Br J Pharmacol; 1983 Oct; 80(2):377-85. PubMed ID: 6606460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures.
    Nutt DJ; Green AR; Grahame-Smith DG
    Neuropharmacology; 1980 Sep; 19(9):897-900. PubMed ID: 7422100
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.
    Cowen PJ; Grahame-Smith DG; Green AR; Heal DJ
    Br J Pharmacol; 1982 Jun; 76(2):265-70. PubMed ID: 6124294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks.
    Nutt DJ; Smith SL; Heal DJ
    Neuropharmacology; 1982 Sep; 21(9):881-4. PubMed ID: 7145040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.
    Heal DJ; Green AR; Bloomfield MR; Grahame-Smith DG
    Psychopharmacology (Berl); 1978 Apr; 57(2):193-7. PubMed ID: 26101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.